ResearcherUniversity of OxfordActive in the last 2 years
Keaton Ian Jones
Matched on ORCID iD 0000-0002-4765-2167; OpenAlex author ID A5058316303. Sources: OpenAlex.
Their work
- Papers
- 5 (first author 1, last author 1)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 18
2017: 2 papers · 2018: none · 2019: none · 2020: none · 2021: none · 2022: none · 2023: none · 2024: 2 papers · 2025: 1 paper
Papers 5
- Induction of macrophage efferocytosis in pancreatic cancer via PI3Kγ inhibition and radiotherapy promotes tumour control. Last author DOI 10.1136/gutjnl-2024-333492↗
- Targeted irradiation in an autochthonous mouse model of pancreatic cancer. Co-author DOI 10.1242/dmm.050463↗
- Tissue-resident natural killer cells support survival in pancreatic cancer through promotion of cDC1-CD8 T activity. Co-author DOI 10.7554/elife.92672↗
- Gemcitabine-Induced TIMP1 Attenuates Therapy Response and Promotes Tumor Growth and Liver Metastasis in Pancreatic Cancer. First author DOI 10.1158/0008-5472.can-16-2833↗
- PD-L1 blockade enhances response of pancreatic ductal adenocarcinoma to radiotherapy. Co-author DOI 10.15252/emmm.201606674↗
Closest collaborators
The 18 strongest of 18 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Jennifer P. Morton · 3 shared papers, 2024–2025 · strength 0.62
- Paper Induction of macrophage efferocytosis in pancreatic cancer via PI3Kγ inhibition and radiotherapy promotes tumour contro… DOI 10.1136/gutjnl-2024-333492↗
- Paper Targeted irradiation in an autochthonous mouse model of pancreatic cancer. DOI 10.1242/dmm.050463↗
- Paper Tissue-resident natural killer cells support survival in pancreatic cancer through promotion of cDC1-CD8 T activity. DOI 10.7554/elife.92672↗
- Eric E. O’Neill · 3 shared papers, 2017–2025 · strength 0.46
- Paper Induction of macrophage efferocytosis in pancreatic cancer via PI3Kγ inhibition and radiotherapy promotes tumour contro… DOI 10.1136/gutjnl-2024-333492↗
- Paper Tissue-resident natural killer cells support survival in pancreatic cancer through promotion of cDC1-CD8 T activity. DOI 10.7554/elife.92672↗
- Paper Gemcitabine-Induced TIMP1 Attenuates Therapy Response and Promotes Tumor Growth and Liver Metastasis in Pancreatic Canc… DOI 10.1158/0008-5472.can-16-2833↗
- Mathias Tesson · 2 shared papers, 2024–2025 · strength 0.44
- Simei Go · 2 shared papers, 2024–2025 · strength 0.40
- Paper Induction of macrophage efferocytosis in pancreatic cancer via PI3Kγ inhibition and radiotherapy promotes tumour contro… DOI 10.1136/gutjnl-2024-333492↗
- Paper Tissue-resident natural killer cells support survival in pancreatic cancer through promotion of cDC1-CD8 T activity. DOI 10.7554/elife.92672↗
- Owen James Sansom · 3 shared papers, 2017–2024 · strength 0.34
- Paper Targeted irradiation in an autochthonous mouse model of pancreatic cancer. DOI 10.1242/dmm.050463↗
- Paper PD-L1 blockade enhances response of pancreatic ductal adenocarcinoma to radiotherapy. DOI 10.15252/emmm.201606674↗
- Paper Gemcitabine-Induced TIMP1 Attenuates Therapy Response and Promotes Tumor Growth and Liver Metastasis in Pancreatic Canc… DOI 10.1158/0008-5472.can-16-2833↗
- Shannon Nicole Russell · 1 shared paper, 2025 · strength 0.22
- Frances W. Willenbrock · 1 shared paper, 2025 · strength 0.22
- Alex Nicolas Gordon-Weeks · 1 shared paper, 2025 · strength 0.22
- Eric O’Neill · 1 shared paper, 2024 · strength 0.22
- Simone Lanfredini · 1 shared paper, 2024 · strength 0.18
- Rachael J. M. Bashford-Rogers · 1 shared paper, 2024 · strength 0.18
- Somnath Mukherjee · 1 shared paper, 2024 · strength 0.18
- Shivan Sivakumar · 1 shared paper, 2024 · strength 0.18
- Zenobia D’Costa · 2 shared papers, 2017 · strength 0.12
- Ruth J. Muschel · 2 shared papers, 2017 · strength 0.12
- Emmanouil Fokas · 2 shared papers, 2017 · strength 0.12
- Abul Kalam Azad · 2 shared papers, 2017 · strength 0.12
- Angela Diana · 1 shared paper, 2017 · strength 0.06
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.